Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #151, June 2020
A Florida federal judge has recused himself from a C.R. Bard inferior vena cava filter action on the basis that his court reporter’s sister is a plaintiff in a similar action pending in the same court.
A California man has sued GlaxoSmithKline in state court, alleging that its popular over-the-counter antacid Zantac contains “staggering amounts” of N-nitrosodimethylamine (NDMA), causing him to develop prostate cancer.
Illinois courts may not exercise specific personal jurisdiction over Bayer Essure personal injury claims filed by out-of-state plaintiffs who did not undergo implantation of the birth control device in Illinois, the state high court has ruled.
Defendants in actions alleging injuries caused by Covidien hernia mesh products have asked the Judicial Panel for Multidistrict Litigation to create a coordinated federal docket for the cases, noting the panel has already established four MDLs for hernia mesh litigation.
The judge overseeing the Taxotere multidistrict litigation docket has dismissed the claims of certain plaintiffs who took the drug before Dec. 15, 2006, finding that under Louisiana law, defendants did not have a duty to warn of the risk of alopecia before that date.
A Delaware federal magistrate judge has opined that a failure-to-warn claim against GE Healthcare in a gadolinium-based contrast agent case is preempted because the plaintiff failed to identify any newly acquired information that would have supported a label change via the Changes Being Effected regulation.
A California federal judge has dismissed MicroPort Orthopedics Inc. from a Wright Profemur hip action, ruling that MicroPort did not assume Wright Medical’s liability in acquiring the company’s hip and knee division.
A Washington federal judge has dismissed a lawsuit accusing Merck Sharp & Dohme Corp. of failing to warn that its cancer treatment can cause permanent bladder damage, ruling that the complaint “severely lacks non-conclusory factual allegations that state a plausible claim for relief.”
A Pennsylvania federal judge has refused to create a new “FDA exception” to the learned intermediary doctrine in an amiodarone wrongful death action, ruling that “it would break new ground and significantly expand liability” under commonwealth law.
A federal appeals court has upheld dismissal of a silicone breast implant action, finding the claims are preempted because the plaintiff failed to sufficiently allege that Mentor Worldwide LLC violated state law claims that are parallel to federal regulations.